Dual cell cycle blockade and immune checkpoint inhibition as a potential strategy of sequential anticancer therapy
2025/57/N/NZ7/03645
Keywords
Descriptors
- NZ7_08: Skuteczność terapii, w tym oporność na terapie
- NZ4_12: Nowotwory
- NZ6_11: Innowacyjne narzędzia i metody immunologiczne, w tym terapie
Panel
NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution
Uniwersytet Jagielloński
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 24 – announced on 2025-03-17
- Amount awarded
- 209 840 PLN
- Project start date
- 2026-02-09
- Project end date
- 2029-02-08
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.